US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
Reuters
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
Eli Lilly and Company
Live trending content β automatically surfaced from public trends & news. SocialTrends only shows what's currently trending; it doesn't create, endorse, or verify it and isn't responsible for third-party content.